Evidence map›Paper›PMID 26002841›Full record

ReviewFEMS yeast research2015

System-level impact of mitochondria on fungal virulence: to metabolism and beyond.

Richard Calderone, Dongmei Li, Ana Traven

Open access · bronzeAbstract readReview
In one paragraph

Review in FEMS yeast research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Functional role ofVirulence · 2025
    Article
  8. Low-level direct currents eradicate multi-drug-resistantChemical engineering journal (Lausanne, Switzerland : 1996) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Polystyrene nanoparticles reduce theFrontiers in cellular and infection microbiology · 2025
    Article
  15. Deciphering cargo contents in extracellular vesicles ofComputational and structural biotechnology journal · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Richard CalderoneDepartment of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC 20057, USA.
Dongmei LiDepartment of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC 20057, USA.
Ana TravenDepartment of Biochemistry and Molecular Biology, Monash University Clayton, 3800 VIC, Australia ana.traven@monash.edu.
Georgetown University Medical Center · USMonash University · AU

Funding

Novel antifungal therapeuticsR21AI090290 · NIAID · GEORGETOWN UNIVERSITY · PI CALDERONE, RICHARD ARTHUR, GROUTAS, WILLIAM CONSTANTINE · 2011 to 2012
$387k
NIAID NIH HHS AI090290
6 · The paper itself

Abstract

The mitochondrion plays wide-ranging roles in eukaryotic cell physiology. In pathogenic fungi, this central metabolic organelle mediates a range of functions related to disease, from fitness of the pathogen to developmental and morphogenetic transitions to antifungal drug susceptibility. In this review, we present the latest findings in this area. We focus on likely mechanisms of mitochondrial impact on fungal virulence pathways through metabolism and stress responses, but also potentially via control over signaling pathways. We highlight fungal mitochondrial proteins that lack human homologs, and which could be inhibited as a novel approach to antifungal drug strategy.

Indexed as

Energy MetabolismFungiGene Expression Regulation, FungalMitochondriaSignal TransductionStress, PhysiologicalVirulenceCandida albicansfungal pathogenesismitochondria

Identifiers

PMID26002841
PMCPMC4542695
OpenAlexW341279500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.